Skip to content

Melanie is a partner in the Corporate department. She specialises in venture capital work as well as regularly advising clients on M&A and corporate restructuring matters.

A large part of Melanie’s practice comprises venture capital investment work and within that she has a particular specialism in the life sciences and medtech sectors, advising both funders and companies taking investment, from start-ups (including university spin-outs) through to more established businesses. Melanie is passionate about the thriving life science sector in the North West and has close connections with Alderley Science Park, the UK’s largest single-site life science campus.

Melanie also advises on management buy-outs/buy-ins and corporate disposals and acquisitions along with share reorganisations for clients.


Melanie has over 20 years of experience in advising on corporate transactional matters.

Recent matters include:

  • Advising Catapult Ventures on its investment in Blueberry Therapeutics
  • Advising Catapult Ventures on its investment in Microbiosensor
  • Advising Catapult Ventures on its investment in Biorelate
  • Advising NPIF NW Equity LP on its investment in Relative Insight
  • Advising NPIF YHTV on its investment in Intechnica
  • Advising the selling shareholders on the sale of the entire issued share capital of Syntor Fine Chemicals Holdings Limited
  • Advising the management team on the management buy-out of Venturi (recruitment consultants)
  • Acting for The Greater Manchester Investment Fund on a number of equity investments

What people say

  • We went into this deal with little experience of corporate legal matters but were guided through every step by Melanie and her team; true professionals and a pleasure to work with.

    Simon Knowles, Managing Director, Syntor Fine Chemicals

My insights